Skip to main content

Advertisement

Table 1 Characteristics of participants in each survey

From: Identifying potential indicators to measure the outcome of translational cancer research: a mixed methods approach

  Qualitative study n (%) (n = 23) Delphi first round n (%) (n = 35)
Years of experience in cancer research   
5–9 7 (30) 5 (14)
10–14 2 (9) 4 (12)
15–19 5 (22) 4 (12)
20–24 2 (9) 11 (31)
25–29 5 (21) 6 (17)
≥30 2 (9) 5 (14)
Sex   
Male 16 (70) 24 (69)
Female 7 (30) 11 (31)
Institution of affiliation type   
Comprehensive cancer centre 11 (48) 17 (49)
University hospital 6 (26) 11 (31)
Public research institute (not affiliated to a hospital or cancer centre) 2 (9) 4 (11)
National agency 2 (9) 0
International or European agency 2 (9) 0
Industry (pharmaceutical or consulting) 0 3 (9)
Country   
French institution 18 (79) 3 (9)
Italian institution 1 (4) 8 (23)
Dutch institution 0 6 (17)
British institution 0 4 (11)
Belgian institution 0 3 (9)
Other European country institution 3 (13) 11 (31)
International institution 1 (4) 0
Training   
Masters degree (MSc) 0 1 (3)
Medical degree (MD) 2 (9) 7 (20)
Medical degree and MSc 1 (4) 0
Medical degree and PhD 7 (30) 14 (40)
Pharmacy degree (PharmaD) 1 (4) 0
Pharmacy degree and PhD 5 (22) 1 (3)
PhD 7 (30) 12 (34)
PhD or MSc specialisation 20 28
Biology 10 (50) 13 (46)
Chemistry or biochemistry 2 (10) 2 (7)
Pharmacology 2 (10) 0
Physics 2 (10) 2 (7)
Computer sciences 1 (5) 0
Management of healthcare organisations 0 2 (7)
Immunology 1 (5) 2 (7)
Genetics 1 (5) 3 (10)
Epidemiology/statistics 0 2 (7)
Biotechnology 1 (5) 1 (4)
Pathology 0 1 (4)
  1. Note: Two participants took part in both studies.